The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

DPH DECHRA PHARMACEUTICALS PLC ORD 1P




We are now using data from FTSE Russell Data Solutions. FTSE Russell is a leading global provider of benchmarks, analytics and data solutions with multi-asset capabilities. Global Company Fundamentals provides profiles on global active and inactive companies from over 100 countries including over 25 years of as-reported financials and standardised financials based on globally accepted XBRL taxonomies for active companies. As a result of this change in data provider, you may see some differences to the data. For further information please contact lse-website@lseg.com
Income Statement 30-Jun-13
( £ m )
30-Jun-14
( £ m )
30-Jun-15
( £ m )
30-Jun-16
( £ m )
30-Jun-17
( £ m )
Continuing Operations
Revenue  189.18 193.57 203.48 247.56 359.28
Operating Profit/(Loss)  18.34 25.00 25.98 19.49 33.21
Net Interest  -5.20 -2.47 -1.47 -2.37 -4.85
Profit Before Tax  12.48 21.44 25.81 14.55 28.72
Profit After Tax  10.85 19.42 19.46 12.51 26.27
Discontinued Operations
Profit After Tax  7.06 39.63 n/a n/a n/a
PROFIT FOR THE PERIOD  17.91 59.05 19.46 12.51 26.11
Attributable to:
Minority Interests  n/a n/a n/a 0.16 0.00
Equity Holders of Parent Company  17.91 59.05 19.46 12.67 26.10
 
Continuing EPS
Earnings per Share - Basic  12.47p 22.22p 22.14p 14.00p 28.09p
Earnings per Share - Diluted  12.39p 22.14p 21.99p 13.90p 27.93p
Earnings per Share - Adjusted  n/a n/a n/a n/a n/a
Continuing and Discontinued EPS
Earnings per Share - Basic  20.59p 67.57p 22.14p 14.00p 28.09p
Earnings per Share - Diluted  20.45p 67.33p 21.99p 13.90p 27.93p
Earnings per Share - Adjusted  n/a n/a n/a n/a n/a
 
Dividend per Share  n/a n/a 16.94p 18.46p 21.44p

Balance Sheet 30-Jun-13
( £ m )
30-Jun-14
( £ m )
30-Jun-15
( £ m )
30-Jun-16
( £ m )
30-Jun-17
( £ m )
Assets
Non-Current Assets
Property, Plant & Equipment  16.07 18.26 16.82 37.72 45.20
Intangible Assets  219.60 196.18 166.68 360.38 396.26
Investment Properties  n/a n/a n/a n/a n/a
Investments  n/a n/a n/a n/a 10.85
Other Financial Assets  n/a n/a n/a n/a n/a
Other Non-Current Assets  0.00 0.00 0.00 0.00 0.00
  235.67 214.44 183.51 398.30 453.09
Current Assets
Inventories  29.20 29.67 31.74 54.38 56.51
Trade & Other Receivables  27.68 29.89 30.93 68.94 67.27
Cash at Bank & in Hand  32.79 26.77 45.95 39.14 61.20
Current Asset Investments  n/a n/a n/a n/a n/a
Other Current Assets  0.00 0.00 0.00 0.00 0.00
  179.46 86.33 108.62 162.46 184.98
 
Total Assets  415.13 300.77 292.13 560.75 638.07
 
Liabilities
Current Liabilities
Borrowings  9.75 0.10 0.01 1.67 0.97
Other Current Liabilities  81.91 22.74 33.73 40.26 44.00
  103.52 35.72 44.11 66.26 66.41
 
Net Current Assets  75.94 50.62 64.52 96.20 118.56
 
Non-Current Liabilities
Borrowings  103.84 31.66 32.52 154.09 180.19
Provisions  n/a n/a n/a n/a n/a
Other Non-Current Liabilities  4.97 6.02 3.41 6.50 36.55
  136.99 60.25 53.53 217.88 269.02
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  240.51 95.97 97.64 286.12 337.00
 
Net Assets  174.62 204.81 194.49 274.63 301.07
 
Capital & Reserves
Share Capital  n/a n/a 0.88 0.93 0.93
Share Premium Account  123.48 124.43 124.80 172.45 173.38
Other Reserves  n/a n/a n/a n/a n/a
Retained Earnings  39.38 87.49 94.98 94.00 107.42
Shareholders Funds  174.62 204.81 194.49 274.63 301.07
 
Minority Interests/Other Equity  n/a n/a n/a 1.98 1.56
Total Equity *   174.62 204.81 194.49 276.61 302.64

Ratios - based on IFRS 30-Jun-13 30-Jun-14 30-Jun-15 30-Jun-16 30-Jun-17
Continuing Operations
PE Ratio *   55.33 32.56 44.40 83.71 60.52
PEG *   1.73 0.14 -0.66 -2.27 0.60
Earnings per Share Growth  31.93% 228.17% -67.23% -36.94% 101.19%
Dividend Cover *   n/a n/a 1.31 0.76 1.31
Revenue Per Share  217.42p 221.51p 231.52p 276.22p 386.47p
Pre-Tax Profit per Share  14.34p 24.54p 29.36p 16.23p 30.90p
Operating Margin  9.69% 12.91% 12.77% 7.87% 9.24%
Return on Capital Employed  n/a n/a n/a n/a n/a
 
Continuing & Discontinued Operations
Dividend Yield *   n/a n/a 1.72% 1.58% 1.26%
Dividend per Share Growth  n/a n/a n/a 8.68% 16.46%
Net Asset Value per Share (exc. Intangibles)  -51.61p 9.83p 31.61p -92.46p -102.16p
Net Gearing *   46.27% 2.44% -6.90% 42.47% 39.84%

Data provided by FTSE Russell




Company Information
Updated Monthly
Company address 24 Cheshire Avenue, Cheshire Business Park, Lostock Gralam, Northwich, CW9 7UA, United Kingdom
Company website http://www.dechra.com
Market cap(in millions)* £ 1,847.19
Listing/Admission to trading 21 Sep 2000
Trading service SETS
Market Main Market
Listing category Premium Equity Commercial Companies
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
17-Jan-18
FTSE index FTSE All-Share,FTSE 350 Low Yield,FTSE 250,FTSE All-Share (ex IT),FTSE 350 (ex IT),FTSE MID 250 (ex IT),FTSE 350
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment STMM
MiFID Status Regulated Market
Exchange market size 750
SEDOL 0963318
ISIN number GB0009633180



DECHRA PHARM share fundamentals (DPH)